LifeStance Health (LFST) Director Teresa DeLuca Sells 7,500 Shares

What Happened

• Teresa DeLuca, a director of LifeStance Health Group, sold 7,500 shares on August 14, 2026. The weighted-average price reported was $12.68 (individual trades ranged $12.68–$12.695), producing gross proceeds of approximately $95,100. This was a sale (S) reported on Form 4.
• The filing’s footnote indicates this was a "sell to cover" to satisfy tax withholding obligations related to the vesting of restricted stock units, not a discretionary sale for investment purposes.

Key Details

• Transaction date: 2026-08-14 (Filed with SEC: 2026-08-18; filing appears timely)
• Shares sold: 7,500; weighted-average price: $12.68; range reported: $12.68–$12.695
• Proceeds: ~$95,100
• Shares owned after transaction: Not disclosed in the provided filing excerpt
• Notable footnotes: F1 — sale to cover tax withholding for RSU vesting (not discretionary); F2 — weighted-average price with multiple trade prices; reporting person will provide breakdown of shares sold at each price upon request

Context

• "Sell to cover" transactions are routine when restricted stock units vest and the company or insider sells a portion to cover tax obligations; they generally do not signal the insider’s overall view of the stock.
• The filing reports an open market/private sale; the weighted-average price and price range reflect multiple trades.